The Board proposes the rule promulgation to create a rule regarding Nonresident Sterile Compounding Permits – Mandatory Notification for a Change in Pharmacy Name and Change in Prescription Department Manager.

 

DEPARTMENT OF HEALTH

Board of Pharmacy

RULE NO.:RULE TITLE:

64B16-32.011Nonresident Sterile Compounding Permits - Mandatory Notification for a Change in Pharmacy Name and Change in Prescription Department Manager.

PURPOSE AND EFFECT: The Board proposes the rule promulgation to create a rule regarding Nonresident Sterile Compounding Permits – Mandatory Notification for a Change in Pharmacy Name and Change in Prescription Department Manager.

SUMMARY: A rule will be created regarding Nonresident Sterile Compounding Permits – Mandatory Notification for a Change in Pharmacy Name and Change in Prescription Department Manager.

SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS AND LEGISLATIVE RATIFICATION: The Agency has determined that this will not have an adverse impact on small business or likely increase directly or indirectly regulatory costs in excess of $200,000 in the aggregate within one year after the implementation of the rule. A SERC has not been prepared by the Agency.

The Agency has determined that the proposed rule is not expected to require legislative ratification based on the statement of estimated regulatory costs or if no SERC is required, the information expressly relied upon and described herein: During discussion of the economic impact of this rule at its Board meeting, the Board, based upon the expertise and experience of its members, determined that a Statement of Estimated Regulatory Costs (SERC) was not necessary and that the rule will not require ratification by the Legislature. No person or interested party submitted additional information regarding the economic impact at that time.

Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.

RULEMAKING AUTHORITY: 465.005, 465.0158(8) FS.

LAW IMPLEMENTED: 465.0158, 456.065(3) FS.

IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN THE FAR.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Allison Dudley, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin C04, Tallahassee, Florida 32399-3254

 

THE FULL TEXT OF THE PROPOSED RULE IS:

 

64B516-32.011 Nonresident Sterile Compounding Permits – Mandatory Notification for a Change in Pharmacy Name and Change in Prescription Department Manager.

(1) A change in the pharmacy name or a change in the prescription department manager, pharmacist in charge, or the equivalent (i.e., supervising pharmacist) for a nonresident sterile compounding permit for nonresident pharmacies and for nonresident sterile compounding permit for outsourcing facilities shall be timely reported to the board office within 30 calendar days.

(2) If there is a change in the pharmacy name, the department shall issue an updated duplicate permit that reflects the name change. 

(3) If a duplicate permit is required to be issued pursuant to subsection (2), the permit holder shall pay a $25.00 duplicate permit fee before the duplicate permit shall be released.

(4) Any notification required by this section shall be mailed to the Florida Board of Pharmacy, Bin C-04, Tallahassee, Florida 32399. If a duplicate permit is required, make the check or money order payable to the Department of Health.

Rulemaking Authority 465.005, 465.0158(8) FS.  Law Implemented 465.0158, 456.065(3) FS. History – New ______________.

 

NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Pharmacy

NAME OF AGENCY HEAD WHO APPROVED THE PROPOSED RULE: Board of Pharmacy

DATE PROPOSED RULE APPROVED BY AGENCY HEAD: April 5, 2016

DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAR: May 9, 2016